/Investor DB

M Ventures — 2017 Investments

8 investments dated 2017 · listed companies and verified rows first · show all

Indi Molecularindimolecular.cominJun 2017 · $11.5M✓ verified

Indi Molecular develops small-molecule oncology therapeutics based on protein-catalyzed capture agents (PCCs) created through click chemistry, a synthetic process developed in collaboration with Caltech.

BiotechDeep TechMedical DevicesCulver City, US

James Heath(Director)Leroy Hood(Director)Andreas Jurgeit(Director)inHeather Agnew(Executive Officer)Albert Luderer(Executive Officer, Director)Darren Cai(Director)

Co-investorsLegend CapitalAsset Management CompanyAsset Management Ventures

Geniesgenies.comDec 2017 · $3M

Genies creates AI personas with visual avatars that can be customized and deployed across various applications, games, websites, and brands, functioning as AI companions, NPCs, and enterprise agents.

AI & Machine LearningConsumerGamingLos Angeles, US

Akash Nigam(Founder)inEvan Rosenbaum(Founder)inAkash Nigam Evan Rosenbaum(Founder)

Co-investorsA.Capital VenturesBase Venture Management, Inc.Bond Capital ManagementBreyer CapitalCoinbase VenturesCoinFund+29 more

Inthera Bioscienceintherabio.comSeries A · May 2017 · $11M

Inthera Bioscience AG is a biotech company with expertise spanning target discovery, drug discovery, medicinal chemistry, preclinical and toxicology work, and early clinical development.

BiotechDeep Tech

Mark Krul(Board of Directors)inKarl Rothweiler(Board of Directors)Martin Bonde(Board of Directors)

Co-investorsForbion

LabGeniuslabgeni.usin𝕏Oct 2017

LabGenius develops EVA, an automated discovery engine for identifying and co-optimizing complex therapeutic antibodies such as multispecifics across multiple properties.

AI & Machine LearningBiotechDeep TechLondon

Harrison Rickerby(Executive Officer, Director)

BoardJames Field(Founder)in

Co-investorsAcequia Capital (AceCap)Air Street CapitalAtomicoBackedBeast VenturesChampion Hill Ventures+9 more

LifeMine Therapeuticslifeminetx.cominSep 2017

LifeMine is a biopharmaceutical company that uses data science and advanced methods to accelerate drug discovery and develop precision medicines across therapeutic areas.

AI & Machine LearningBiotechDeep TechCambridge, US

Gregory L. Verdine(Executive Officer, Director)Gregory Verdine, Ph.D.

BoardHingge Hsu(Executive Officer, Director)Weiqing Zhou(Executive Officer, Director)

Co-investorsARCH Venture PartnersGV (Google Ventures)RA CapitalAisling CapitalAlexandriaBezos Expeditions+7 more

Mass Appealmassappeal.com𝕏Series A · Mar 2017 · $6M

Mass Appeal is a media company focused on hip-hop culture, producing content and products including new music releases in partnership with Sony Music, photography, and cultural events.

Media & EntertainmentNew York, US

Peter Bittenbender(Director)David M. Mars(Director)

Co-investorsMaC Venture CapitalWhite Owl Capital

Remezclaremezcla.comin𝕏Series A · Aug 2017 · $5M

Remezcla is a digital media publication covering Latino and Latin American culture, including music, film, and food, through articles and interviews.

ConsumerMedia & EntertainmentBrooklyn, US

Andrew Herrera(CEO & Founder)inClaire Frisbie(Co-founder)inNuria Net(Co-founder)inEduardo Goya(Executive Officer)in

BoardAlan Sokol(Director)

Co-investorsMaC Venture Capital

Other

Tracked investments with no reachable website or further public details — typically companies that wound down, renamed, or were absorbed.

ARTSaVIT

Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.